Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC2A1 | P11166 | 7/20 | 0.35 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.34 |
| ▸ | KCNH2 | Q12809 | 6/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5437838 | 0.89 | KCNH2 (0.33) | SLC2A1KCNH2 | |
| SCHEMBL3688036 | 0.87 | SLC2A1 (0.46) | SLC2A1KCNH2ALDH1A1 | |
| SCHEMBL5263326 | 0.85 | SLC2A1 (0.36) | SLC2A1MCHR1KCNH2 | |
| SCHEMBL3690361 | 0.82 | SLC2A1 (0.39) | SLC2A1MCHR1KCNH2 | |
| SCHEMBL5316419 | 0.82 | KCNH2 (0.36) | SLC2A1KCNH2 | |
| SCHEMBL5434491 | 0.80 | KCNH2 (0.39) | SLC2A1MCHR1KCNH2 | |
| SCHEMBL5427562 | 0.78 | SLC2A1 (0.42) | SLC2A1MCHR1KCNH2ALDH1A1 | |
| SCHEMBL5427041 | 0.77 | KCNH2 (0.49) | SLC2A1MCHR1KCNH2ALDH1A1 | |
| SCHEMBL5374313 | 0.77 | KCNH2 (0.54) | SLC2A1MCHR1KCNH2ALDH1A1 | |
| SCHEMBL5432414 | 0.77 | KCNH2 (0.45) | SLC2A1KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070244103-A1 | Novel Compounds Having an Anti-Bacterial Activity | MORPHOCHEM AKTIENGESELLSCHAFT FUR KOMBINATORISCHE CHEMIE (DE) | 2007-10-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070244103-A1 | Novel Compounds Having an Anti-Bacterial Activity | TOP1, TOP2A, TOP2B | SLC2A1 4714/4885MCHR1 4372/4885KCNH2 3363/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.